Abstract

BackgroundMutations in the coding region of angiogenin (ANG) gene have been found in patients suffering from Amyotrophic Lateral Sclerosis (ALS). Neurodegeneration results from the loss of angiogenic ability of ANG (protein coded by ANG). In this work, we performed extensive molecular dynamics (MD) simulations of wild-type ANG and disease associated ANG variants to elucidate the mechanism behind the loss of ribonucleolytic activity and nuclear translocation activity, functions needed for angiogenesis.Methodology/Principal FindingsMD simulations were carried out to study the structural and dynamic differences in the catalytic site and nuclear localization signal residues between WT-ANG (Wild-type ANG) and six mutants. Variants K17I, S28N, P112L and V113I have confirmed association with ALS, while T195C and A238G single nucleotide polymorphisms (SNPs) encoding L35P and K60E mutants respectively, have not been associated with ALS. Our results show that loss of ribonucleolytic activity in K17I is caused by conformational switching of the catalytic residue His114 by 99°. The loss of nuclear translocation activity of S28N and P112L is caused by changes in the folding of the residues 31RRR33 that result in the reduction in solvent accessible surface area (SASA). Consequently, we predict that V113I will exhibit loss of angiogenic properties by loss of nuclear translocation activity and L35P by loss of both ribonucleolytic activity and nuclear translocation activity. No functional loss was inferred for K60E. The MD simulation results were supported by hydrogen bond interaction analyses and molecular docking studies.Conclusions/SignificanceConformational switching of catalytic residue His114 seems to be the mechanism causing loss of ribonucleolytic activity and reduction in SASA of nuclear localization signal residues 31RRR33 results in loss of nuclear translocation activity in ANG mutants. Therefore, we predict that L35P mutant, would exhibit loss of angiogenic functions, and hence would correlate with ALS while K60E would not show any loss.

Highlights

  • Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disorder

  • The objective of our simulation study was to determine the underlying cause for the loss of ribonucleolytic activity and nuclear translocation activity of ANG reported in ALS patients, and predict the role of certain single nucleotide polymorphisms (SNPs) reported in ANG but not yet clinically correlated in ALS patients

  • Through the results of this investigation, we have established that the conformational switching of His114 of the catalytic triad of ANG is responsible for the loss of ribonucleolytic activity

Read more

Summary

Introduction

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disorder It is caused by selective destruction of motor neurons [1]. Among the catalogued ALS-like motor neuron diseases, mutations in SOD1 (ALS1), FUS/TLS (ALS6), VAPB (ALS8), ANG (ALS9), TARDBP (ALS10), FIG4 (ALS11) and a hexanucleotiderepeat expansion (GGGGCC) in the C9ORF72 cause adult onset neurodegenerative disorder [2,3,4]. Among the ALS types that portray the characteristic adult onset neurodegenerative disorders, about one-fifth of the familial cases are attributed to missense mutations in the gene that encodes SOD1. Mutations in SOD1 gene cause ALS through a toxic gain of function and not due to an impairment of its antioxidant function [7] and SOD1 mimetics may not lead to an effective therapy. We performed extensive molecular dynamics (MD) simulations of wild-type ANG and disease associated ANG variants to elucidate the mechanism behind the loss of ribonucleolytic activity and nuclear translocation activity, functions needed for angiogenesis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call